- Nachrichtendetail
-
01.11.2023 21:16:30 - dpa-AFX: Biomarin Pharmaceutical Inc. Q3 Earnings Summary
WASHINGTON (dpa-AFX) - Below are the earnings highlights for Biomarin
Pharmaceutical Inc. (BMRN):
Earnings: $40.38 million in Q3 vs. -$6.65 million in the same period last year.
EPS: $0.21 in Q3 vs. -$0.04 in the same period last year.
Excluding items, Biomarin Pharmaceutical Inc. reported adjusted earnings of
$89.5 million or $0.46 per share for the period.
Analysts projected $0.22 per share
Revenue: $581.33 million in Q3 vs. $505.34 million in the same period last year.
Copyright(c) 2023 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Pharmaceutical Inc. (BMRN):
Earnings: $40.38 million in Q3 vs. -$6.65 million in the same period last year.
EPS: $0.21 in Q3 vs. -$0.04 in the same period last year.
Excluding items, Biomarin Pharmaceutical Inc. reported adjusted earnings of
$89.5 million or $0.46 per share for the period.
Analysts projected $0.22 per share
Revenue: $581.33 million in Q3 vs. $505.34 million in the same period last year.
Copyright(c) 2023 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
BIOMARIN PHAR. DL-,001 | 924801 | Frankfurt | 75,660 | 10.05.24 08:04:45 | -0,120 | -0,16% | 0,000 | 0,000 | 75,660 | 75,660 |
